At first I was dismayed that the uplisting was taking so long, but I think the reason is that Nasdaq has to review all the financial statements from each of the companies that GNBT is acquiring, not just GNBT itself.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links